Analysis finds TLS as a promising biomarker for antitumor immunity in epithelial ovarian carcinoma, suggesting potential for immunotherapy.
The prognostic impact of TLS, specifically in pre-chemotherapy specimens, and a positive association between TLS and PD-L1 indicate the potential of TLS as a meaningful biomarker for understanding antitumor immunity and developing immunotherapy for EOC.
No takes yet. Share an insight, caveat, or question.
Nakao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: